2026 NPPES data Allergy & Immunology Physician NPI 1659303774 M.D.
Verify on CMS →

MARK SCARUPA, M.D.

Allergy & Immunology Physician in WHEATON, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
464
Medicare Part D claims · 132 beneficiaries · Allergy & Immunology Physician avg: 764
MIPS score
99.15/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$125.7K
229 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK SCARUPA, M.D. reported a CMS MIPS final score of 99.15/100 — above the 83.1 national average — and filed 464 Medicare Part D claims in 2023.

99.15/100
MIPS score · +16 vs avg
464
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK SCARUPA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 9% higher than 91% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK SCARUPA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK SCARUPA, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/07/2006

NPI 1659303774

Primary specialty

Allergy & Immunology Physician

Niche

3,390 US NPIs in this specialty

Medicare Part D claims

464 39% vs specialty avg

2023 prescription claims

Specialty avg: 764

MIPS final score

99.15/100 16.05000000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Maryland

How Allergy & Immunology Physician compares to other specialties among Maryland providers

Maryland providers

Allergy & Immunology Physician share within Maryland

1. Allergy & Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy & Immunology Physician share within Maryland

Medicare quality performance — MIPS

MARK SCARUPA, M.D.'s 2023 MIPS final score plotted against the Allergy & Immunology Physician national average

High performer (top quartile)
MIPS Final Score
99.15/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Allergy & Immunology Physician) — 99.15/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Allergy & Immunology Physician) — 99.15/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK SCARUPA, M.D. is a Allergy & Immunology Physician provider practicing in WHEATON, Maryland, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1659303774. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK SCARUPA, M.D. appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding M.D. credentials at 11002 VEIRS MILL RD, WHEATON, MD, 20902, with a listed phone of (301) 962-1605. NPI 1659303774 was issued on 07/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SCARUPA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 464 prescription claims written by this provider, covering 132 Medicare beneficiaries and totaling roughly $593K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.15/100 for the 2023 performance year, compared with the national average of 83.1.

Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11002 VEIRS MILL RD
WHEATON, MD 20902

Provider Details

NPI 1659303774
Specialty Allergy & Immunology Physician
Credentials M.D.
Gender Male
NPI Issued 07/07/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

99.15
Final Score
Avg: 83.1
99
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK SCARUPA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

INSTITUTE FOR ASTHMA AND ALLERGY PC
WHEATON, MD

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK SCARUPA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$125.7K

Largest payer

Genentech USA, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

464
Total Claims
$593K
Total Drug Cost
132
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
791
Total Day Supply
21,713
Generic Drug Cost
$43K
Antibiotic Claims
46

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
1.04
Gender Split
75% female / 25% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Montelukast Sodium
47
Prednisone
45
Ipratropium Bromide
37
Albuterol Sulfate Hfa
Albuterol Sulfate
36
Azelastine-Fluticasone
Azelastine/Fluticasone
34
Azelastine Hcl
29
Triamcinolone Acetonide
17
Dupixent Syringe
Dupilumab
14
Doxycycline Hyclate
13
Azithromycin
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy & Immunology Physician Overview

How MARK SCARUPA, M.D. fits within the Allergy & Immunology Physician landscape nationally.

3,390
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
764
Avg Claims per Provider

MARK SCARUPA, M.D.'s 464 claims are below the specialty average of 764.

Nearby Allergy & Immunology Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as SCARUPA.

Compare Allergy & Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK SCARUPA, M.D.'s specialty?
MARK SCARUPA, M.D. specializes in Allergy & Immunology Physician and practices in WHEATON, Maryland. Credentials: M.D..
How much does MARK SCARUPA, M.D. prescribe under Medicare Part D?
In 2023, MARK SCARUPA, M.D. wrote 464 Medicare Part D claims totaling $593K in drug costs for 132 beneficiaries.
What is MARK SCARUPA, M.D.'s Medicare quality score?
MARK SCARUPA, M.D. has a CMS MIPS Final Score of 99.15/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK SCARUPA, M.D. located?
MARK SCARUPA, M.D. is located at 11002 VEIRS MILL RD, WHEATON, MD, 20902. Phone: (301) 962-1605.
What is MARK SCARUPA, M.D.'s NPI number?
MARK SCARUPA, M.D.'s National Provider Identifier (NPI) is 1659303774, issued on 07/07/2006.
How many Allergy & Immunology Physician providers are there in the US?
There are 3,390 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 764 Medicare Part D claims per year.
What drugs does MARK SCARUPA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK SCARUPA, M.D.'s most frequently prescribed drugs include Montelukast Sodium, Prednisone, Ipratropium Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK SCARUPA, M.D. accept Medicare?
MARK SCARUPA, M.D. appears in CMS Medicare data with 464 Part D claims and 132 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK SCARUPA, M.D.'s credentials?
MARK SCARUPA, M.D.'s NPI is 1659303774 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology